Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Here are five drugs or medical devices that have been approved by the FDA since Nov. 2:
The U.S. Department of Homeland Security issued a vulnerability warning for certain Roche point of care handheld medical devices, according to FDA News.
As the supply shortage of GlaxoSmithKline's shingles vaccine continues, the drugmaker is making plans to ramp up production at a quicker pace, according to Bio Process International.
Reducing supply chain waste is a top priority for hospitals and health systems today, as the shift toward value-based care drives new cost saving initiatives.
By Paul Farnin, Director of Supply Chain Solutions at Cardinal Health
Here are four drugs or medical devices that have been approved by the FDA since Oct. 26:
The FDA authorized 23andMe to market its pharmacogenetic report Oct. 31, marking the agency's first time greenlighting a direct-to-consumer DNA test for this purpose.
As the pressure to reduce supply chain costs escalates, leaders are seeking more price transparency to help inform decisions, especially in relation to big-ticket items like procedural packs.
On its third-quarter earnings call Oct. 30, Pfizer said it is still experiencing manufacturing problems at some Hospira plants, meaning the supply shortage of several common sterile injectable drugs will continue for hospitals, according to Bloomberg.
Specialty pharmaceutical growth poses unique challenges for hospital pharmacies. Effectively managing these high-cost therapies that often have unpredictable demand requires a different inventory management strategy than traditional pharmaceuticals. Therefore, many health systems are turning to a consignment model, to better…
Here are five drugs or medical devices that have been approved by the FDA since Oct. 19: